Age doesn't affect survival outcomes in patients with MDS who receive a HCT

Sunday, December 6, 2015 - 21:51 in Health & Medicine

A prospective study shows age doesn't affect survival outcomes in patients with myelodysplastic syndrome (MDS) who receive a hematopoietic cell transplant.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net